Insider trade

Director received an award of 89.78 TMO derivative securities

Traded Mar 28, 2026 · Filed Mar 31, 2026

Thermo Fisher ScientificTMO

89.78
Derivative units

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Mar 28, 2026
Reporting period: Not applicable
Filed with the SEC: Mar 31, 2026

DirectorGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0000097745-26-000077
Filed / recorded

Mar 31, 2026, 9:03 PM UTC

Added to OQRO

Oct 2, 2026, 12:28 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

THERMO FISHER SCIENTIFIC INC.

Issuer CIK

97745

Ticker

TMO

Reporting person

Scott M Sperling

Relationship

Director

Security

Phantom Stock Units

Table

Derivative (Table II)

Transaction date

Mar 28, 2026

Transaction code

A

Shares / units

89.78

Acquired / disposed

Acquired (A)

Shares owned after

17,591.8

Ownership form

Direct

Amendment

No

Footnotes from the filing

Convertible into Common Stock on a 1-for-1 basis.
Represents stock units credited to the Reporting Person's account as of March?28, 2026, at a price of $473.36 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control.